Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity

BMC Endocrine Disorders

Volumn 12, Issue , 2012, Pages

  Masharani, Umesh ^a   Gjerde, Christine ^a   McCoy, Shelley ^a   Maddux, Betty A ^a   Hessler, Danielle ^a   Goldfine, Ira D ^a   Youngren, Jack F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; CHROMIUM PICOLINATE; LIPID; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL;

EID: 84870184573     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-12-31     Document Type: Article

References (52)

1. Nielsen FH. Controversial Chromium: Does the superstar minearal of the mountebanks receive appropriate attention from clinicians and nutritionists?. Nutr Today 1996, 31(Number 6):226-233.
2. Vincent JB. The nutritional biochemistry of chromium (III) 2007, Amsterdam; Boston: Elsevier.
3. Schwarz K, Mertz W. Chromium(III) and the glucose tolerance factor. Arch Biochem Biophys 1959, 85:292-295. 10.1016/0003-9861(59)90479-5, 14444068.
4. Kim DS, Kim TW, Park IK, Kang JS, Om AS. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats. Metabolism 2002, 51(5):589-594. 10.1053/meta.2002.31985, 11979390.
5. Cefalu WT, Wang ZQ, Zhang XH, Baldor LC, Russell JC. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 2002, 132(6):1107-1114.
6. Shindea UA, Sharma G, Xu YJ, Dhalla NS, Goyal RK. Insulin sensitising action of chromium picolinate in various experimental models of diabetes mellitus. J Trace Elem Med Biol 2004, 18(1):23-32. 10.1016/j.jtemb.2004.03.002, 15487760.
7. Morris B, Gray T, MacNeil S. Evidence for chromium acting as an essential trace element in insulin-dependent glucose uptake in cultured mouse myotubes. J Endocrinol 1995, 144(1):135-141. 10.1677/joe.0.1440135, 7891015.
8. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 1977, 30(4):531-538.
9. Freund H, Atamian S, Fischer JE. Chromium deficiency during total parenteral nutrition. JAMA 1979, 241(5):496-498. 10.1001/jama.1979.03290310036012, 104057.
10. Brown RO, Forloines-Lynn S, Cross RE, Heizer WD. Chromium deficiency after long-term total parenteral nutrition. DigDisSci 1986, 31(6):661-664.
11. Bahijri SM, Alissa EM. Increased insulin resistance is associated with increased urinary excretion of chromium in non-diabetic, normotensive Saudi adults. J Clin Biochem Nutr 2011, 49(3):164-168. 10.3164/jcbn.10-148, 3208011, 22128214.
12. Anderson RA. Chromium, glucose intolerance and diabetes. J Am CollNutr 1998, 17(6):548-555.
13. Hellerstein MK. Is chromium supplementation effective in managing type II diabetes?. NutrRev 1998, 56(10):302-306.
14. Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care 2007, 30(8):2154-2163. 10.2337/dc06-0996, 17519436.
15. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K, Pedersen O. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. JClinInvest 1996, 98(5):1195-1209.
16. Newell-Morris LL, Treder RP, Shuman WP, Fujimoto WY. Fatness, fat distribution, and glucose tolerance in second-generation Japanese-American (Nisei) men. Am J Clin Nutr 1989, 50(1):9-18.
17. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982, 36(5):936-942.
18. Defronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:E214-E223.
19. Bonadonna RC, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA. Obesity and insulin resistance in humans: a dose-response study. Metab Clin Exp 1990, 39(5):452-459. 10.1016/0026-0495(90)90002-T, 2186255.
20. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981, 240(6):E630-E639.
21. Anderson RA, Cheng N, Bryden NA, Polansky MM, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997, 46(11):1786-1791. 10.2337/diabetes.46.11.1786, 9356027.
22. Morris BW, Kouta S, Robinson R, MacNeil S, Heller S. Chromium supplementation improves insulin resistance in patients with Type 2 diabetes mellitus. DiabetMed 2000, 17(9):684-685.
23. Martin J, Wang ZQ, Zhang XH, Wachtel D, Volaufova J, Matthews DE, Cefalu WT. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 2006, 29(8):1826-1832. 10.2337/dc06-0254, 16873787.
24. R Development Core Team R A language and environment for statistical computing http://www.R-project.org/, R Development Core Team R.
25. Wasser WG, Feldman NS, D'Agati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 1997, 126(5):410.
26. Cerulli J, Grabe DW, Gauthier I, Malone M, McGoldrick MD. Chromium picolinate toxicity. Ann Pharmacother 1998, 32(4):428-431. 10.1345/aph.17327, 9562138.
27. Lukaski HC, Siders WA, Penland JG. Chromium picolinate supplementation in women: effects on body weight, composition, and iron status. Nutrition 2007, 23(3):187-195. 10.1016/j.nut.2006.12.001, 17291720.
28. Iqbal N, Cardillo S, Volger S, Bloedon LT, Anderson RA, Boston R, Szapary PO. Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metab Syndr Relat Disord 2009, 7(2):143-150. 10.1089/met.2008.0048, 3135886, 19422140.
29. Cefalu WT, Bell-Farrow AD, Stegner J, Wang ZQ, King T, Morgan T, Terry JG. Effect of chromium picolinate on insulin sensitivity in vivo. Journal of Trace Elements in Experimental Medicine 1999, 12:71-83.
30. Glinsmann WH, Feldman FJ, Mertz W. Plasma chromium after glucose administration. Science 1966, 152(726):1243-1245. 10.1126/science.152.3726.1243, 5939533.
31. Evans GW. The effect of chromium picolinate on insulin controlled parameters in humans. Journal of Biosocial and Med Research 1989, 11:163-180.
32. Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 1994, 17(12):1449-1452. 10.2337/diacare.17.12.1449, 7882815.
33. Wilson BE, Gondy A. Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res Clin Pract 1995, 28(3):179-184. 10.1016/0168-8227(95)01097-W, 8529496.
34. Ravina A, Slezak L, Rubal A, Mirsky N. Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus. The Journal of Trace Elements in Experimental Medicine 1995, 8:183-190.
35. Cheng N, Zhu X, Shi H, Wu W, Chi J, Cheng J, Anderson RA. Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium. The Journal of Trace Elements in Experimental Medicine 1999, 12:55-60.
36. Jovanovic L, Gutierrez M, Peterson CM. Chromium supplementation for women with gestational diabetes mellitus. The Journal of Trace Elements in Experimental Medicine 1999, 12:91-97.
37. Amato P, Morales AJ, Yen SS. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J Gerontol A Biol Sci Med Sci 2000, 55(5):M260-M263. 10.1093/gerona/55.5.M260, 10819315.
38. Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med J 2000, 21(9):831-837.
39. Trow LG, Lewis J, Greenwood RH, Sampson MJ, Self KA, Crews HM, Fairweather-Tait SJ. Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes. Int J Vitam Nutr Res 2000, 70(1):14-18. 10.1024/0300-9831.70.1.14, 10683756.
40. Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, Chowdhury S. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J NutrBiochem 2002, 13(11):690-697.
41. Gunton JE, Cheung NW, Hitchman R, Hams G, O'Sullivan C, Foster-Powell K, McElduff A. Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care 2005, 28(3):712-713. 10.2337/diacare.28.3.712, 15735214.
42. Cefalu WT, Rood J, Pinsonat P, Qin J, Sereda O, Levitan L, Anderson RA, Zhang XH, Martin JM, Martin CK, et al. Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. Metabolism 2010, 59(5):755-762. 10.1016/j.metabol.2009.09.023, 20022616.
43. Racek J, Trefil L, Rajdl D, Mudrova V, Hunter D, Senft V. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol Trace Elem Res 2006, 109(3):215-230. 10.1385/BTER:109:3:215, 16632892.
44. Jain SK, Kahlon G, Morehead L, Dhawan R, Lieblong B, Stapleton T, Caldito G, Hoeldtke R, Levine SN, Bass PF. Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-alpha, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study. Mol Nutr Food Res 2012, 56(8):1333-1341. 10.1002/mnfr.201100719, 22674882.
45. Drake TC, Rudser KD, Seaquist ER, Saeed A. Chromium infusion in hospitalized patients with severe insulin resistance: a retrospective analysis. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2012, 18(3):394-398.
46. Krol E, Krejpcio Z, Byks H, Bogdanski P, Pupek-Musialik D. Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biol Trace Elem Res 2011, 143(2):726-737. 10.1007/s12011-010-8917-5, 21170603.
47. Glinsmann WH, Mertz W. Effect of trivalent chromium on glucose tolerance. Metabolism 1966, 15(6):510-520. 10.1016/0026-0495(66)90111-9, 5933913.
48. Anderson RA, Polansky MM, Bryden NA, Canary JJ. Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets. Am J Clin Nutr 1991, 54(5):909-916.
49. Gargas ML, Norton RL, Paustenbach DJ, Finley BL. Urinary excretion of chromium by humans following ingestion of chromium picolinate. Implications for biomonitoring. Drug Metab Dispos 1994, 22(4):522-529.
50. Davis CM, Sumrall KH, Vincent JB. A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry 1996, 35(39):12963-12969. 10.1021/bi960328y, 8841143.
51. Davis CM, Vincent JB. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 1997, 36(15):4382-4385. 10.1021/bi963154t, 9109644.
52. Wang ZQ, Zhang XH, Russell JC, Hulver M, Cefalu WT. Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. J Nutr 2006, 136(2):415-420.